About Cancer Trials Australia
A not-for-profit, member-based organisation of clinical sites and research institutes across Australia and New Zealand.
Collective expertise, coordinated resources
Our strength lies in the collective medical and intellectual expertise of our members and the coordination of their resources. CTA supports clinical trial administration and management, primarily in oncology, across Australian hospitals.
We were incorporated in 2003 as a public company limited by guarantee and have continued to expand.
Why we exist
CTA supports the administration and management of clinical trials, mostly in oncology, at metropolitan and regional hospitals. We aim to build clinical and industry knowledge and improve outcomes for people affected by cancer, and we advocate for regulatory changes that keep Australia attractive to international trial sponsors.
Vision
To transform care for all by enabling world-class clinical trials.
Mission
To deliver excellence in clinical trial management and advance the Australian trial sector.
Our values
Shared Purpose
We work towards shared goals that improve outcomes for cancer patients.
Integrity
We act ethically and transparently, building trust through honesty.
Collaboration
We share knowledge and work together to advance cancer clinical trials.
Adaptability
We embrace change, respond to challenges and seek better ways of working.
Compassion
We listen with empathy and treat everyone with kindness and respect.
Built by clinicians in 1993. Shaping the sector ever since.
CTA was formed in 1993 as the Centre for Developmental Cancer Therapies (CDCT) by medical oncologists who wanted to run trials of cytokines developed by Professor Don Metcalf at the Walter and Eliza Hall Institute. In 2003 we became a public company limited by guarantee with six founding members. Our work has since grown beyond medical oncology to include disciplines such as radiation oncology and other therapeutic areas.
Beyond Administration: Sector Development
Mutual Acceptance Program
Implemented the national Mutual Acceptance Program (MAP) across CTA members.
Standard Clinical Trial Agreement
Helped develop the standard clinical trial agreement template for sponsored trials, now the Medicines Australia Standard Clinical Trial Research Agreement.
First Time in Human Protocol
Developed a First Time in Human (FTIH) protocol so Human Research Ethics Committees can strengthen their capacity to review early phase research.
Pre-Screening Protocol
Developed a pre-screening protocol allowing patients to be screened at their local hospital for a trial at another hospital.
Phase 1 Fellowship Program
Convened a Phase 1 Fellowship Program to increase the capacity of sites to coordinate First Time in Human trials.
Education and Capacity Building
Administered clinical trial education projects through Victorian Comprehensive Cancer Centre initiatives, and coordinates the Australian Clinical Trials Education Centre (A-CTEC): a learning management system of interactive education for clinical trial staff.
We take part in regulatory reform across the Australian health sector at federal and state levels, and advocate with government and sector peak bodies on behalf of our members.
With support from the Department of Health Victoria through the Victorian Cancer Agency, we now run the Victorian Annual Cancer Clinical Trials Census, previously coordinated by Cancer Council Victoria. The census tracks cancer trial participation in Victoria to inform government policy.
Our reconciliation journey
We welcome site visitors to view our Reflect Reconciliation Action Plan.
Cancer Trials Australia was delighted to unveil our commissioned artwork by Safina Stewart, Aboriginal and Torres Strait Islander artist.
Tell us what you’re working on
Whether you’re a sponsor planning a study in Australia or an organisation considering membership, our team will point you in the right direction.
